Standout Papers

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Respo... 1999 2026 2008 2017 8.8k
  1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib (2004)
    Thomas J. Lynch, Daphne W. Bell et al. New England Journal of Medicine
  2. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development (1999)
    Masaki Okano, Daphne W. Bell et al. Cell
  3. Isolation of rare circulating tumour cells in cancer patients by microchip technology (2007)
    Sunitha Nagrath, Lecia V. Sequist et al. Nature
  4. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells (2012)
    Wanjuan Yang, Jorge Soares et al. Nucleic Acids Research
  5. Epidermal growth factor receptor mutations in lung cancer (2007)
    Sreenath V. Sharma, Daphne W. Bell et al. Nature reviews. Cancer
  6. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition (2013)
    Min Yu, Aditya Bardia et al. Science
  7. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis (2014)
    Nicola Aceto, Aditya Bardia et al. Cell
  8. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus (1990)
    Katherine M. Call, Tom Glaser et al. Cell
  9. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization (1997)
    Matthew Meyerson, Christopher M. Counter et al. Cell
  10. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (2004)
    Raffaella Sordella, Daphne W. Bell et al. Science
  11. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells (2008)
    Shyamala Maheswaran, Lecia V. Sequist et al. New England Journal of Medicine
  12. Circulating tumor cells: approaches to isolation and characterization (2011)
    Min Yu, Shannon L. Stott et al. The Journal of Cell Biology
  13. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib (2005)
    Eunice L. Kwak, Raffaella Sordella et al. Proceedings of the National Academy of Sciences
  14. Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon (2006)
    Michael Overholtzer, Jianmin Zhang et al. Proceedings of the National Academy of Sciences
  15. salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines (2002)
    Nicolas Tapon, Kieran F. Harvey et al. Cell
  16. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations (2008)
    Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology
  17. Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome (1999)
    Daphne W. Bell, Jennifer M. Varley et al. Science
  18. Microfluidic, marker-free isolation of circulating tumor cells from blood samples (2014)
    Murat Karabacak, Philipp S. Spuhler et al. Nature Protocols
  19. BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function (2001)
    Sharon B. Cantor, Daphne W. Bell et al. Cell
  20. Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC Syndrome (1999)
    Jacopo Celli, Pascal H. G. Duijf et al. Cell
  21. Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA (2014)
    Daniel A. Haber, Victor E. Velculescu Cancer Discovery
  22. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials (2005)
    Daphne W. Bell, Thomas J. Lynch et al. Journal of Clinical Oncology
  23. Alternative splicing and genomic structure of the Wilms tumor gene WT1. (1991)
    Daniel A. Haber, Regina Sohn et al. Proceedings of the National Academy of Sciences
  24. Dual Role for Argonautes in MicroRNA Processing and Posttranscriptional Regulation of MicroRNA Expression (2007)
    Sven Diederichs, Daniel A. Haber Cell
  25. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor (1990)
    Daniel A. Haber, Alan Buckler et al. Cell
  26. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. (1989)
    James M. Croop, M Raymond et al. Molecular and Cellular Biology
  27. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors (2015)
    Rachel Litman Flynn, Maya Jeitany et al. Science
  28. Clusters of circulating tumor cells traverse capillary-sized vessels (2016)
    Sam H. Au, Brian D. Storey et al. Proceedings of the National Academy of Sciences

Immediate Impact

13 by Nobel laureates 67 from Science/Nature 184 standout
Sub-graph 1 of 16

Citing Papers

Metabolic reprogramming and cancer progression
2020 StandoutScience
The biology and management of non-small cell lung cancer
2018 StandoutNature
74 intermediate papers

Works of Daniel A. Haber being referenced

Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
and 27 more

Author Peers

Author Last Decade Papers Cites
Daniel A. Haber 34574 25860 19066 286 62.5k
Raghu Kalluri 48220 20553 9364 315 80.9k
Napoleone Ferrara 60705 20350 9901 257 97.7k
Judah Folkman 62209 24238 10772 391 103.7k
David N. Louis 23780 13929 15368 318 62.6k
Kenneth J. Pienta 21478 17615 17167 662 48.6k
Isaiah J. Fidler 21725 20990 7977 496 47.8k
Tyler Jacks 58358 33760 7023 336 86.1k
Lance A. Liotta 34161 16682 5157 650 61.2k
Jean Paul Thiery 33727 19179 5967 550 55.0k
Carlos Cordon‐Cardo 40955 22560 10872 563 67.3k

All Works

Loading papers...

Rankless by CCL
2026